oral GCS inhibitor - Takeda

oral GCS inhibitor

Preclinical, neurodegeneration

scaffold hop from prev. reported GCS inhibitor

J. Med. Chem.

Takeda

Context. T-690 (Takeda) is an oral GCS inhibitor that is brain-penetrant, non-basic, and non-competitive with UDP-glucose. We recently highlighted a glucosylceramide synthase (GCS, aka CGT) inhibitor in Ph. III…


 this content is exclusive to
Premium members

Upgrade to a Premium Drug Hunter membership to unlock the full content and start reading now.